Template:Secondary amyloidosis: Difference between revisions

	Secondary amyloidosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Secondary amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Secondary amyloidosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Secondary amyloidosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Secondary amyloidosis
CDC on Secondary amyloidosis
Secondary amyloidosis in the news
Blogs on Secondary amyloidosis
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Secondary amyloidosis

@@ Line 159: / Line 159: @@
 !
 [[Secondary amyloidosis medical therapy|Medical Therapy]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-[[Secondary amyloidosis interventions|Interventions]]
 |-
 !
@@ Line 185: / Line 179: @@
 |-
 !
-|- bgcolor="PaleTurquoise"
-!
-[[Secondary amyloidosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-[[Secondary amyloidosis future or investigational therapies|Future or Investigational Therapies]]
-|-
-!
 |- bgcolor="CadetBlue"

Latest revision as of 15:45, 10 February 2020